|Generate QR code
Open Access
Subscription Access
Spectrophotometric Method Using the Derivative for the Determination of the Drug Losartan
Abstract
A sensitive, easy, and low-cost method used in the determination of pure forms of losartan and mebeverine hydrochloride, also in pharmaceutical preparations with derivative spectrometry using UV–Vis technology. This method depends on measuring the first derivative of the spectrum using zero cross, peak to base line, and peak area. The linear range of concentrations used was equal to 2–14 ppm for losartan, whereas for mebeverine hydrochloride it was equal to 2–16 ppm in a mixture. For losartan, in the presence of mebeverine hydrochloride, 12 ppm by utilizing peak to baseline correlation coefficients 0.9984, 0.9994, and peak area 0.9972, whereas for mebeverine hydrochloride in the presence of losartan, 12 ppm by utilizing peak to fundamental correlation coefficients 0.9952, 0.9966, 0.9957, and peak area 0.9970, 0.9971, 0.9968, 0.9971. The limit of detection for each drug, losartan and mebeverine hydrochloride, is equal to 0.0113 ppm. The accuracy and precision of the method were estimated by calculating relative standard deviation (RSD%) values less than 3% while maintaining a recovery percentage of acceptable value. The proposed method proved effective and efficient at estimating both losartan and mebeverine hydrochloride, in the presence of the other in a mixture of the two without interference, despite the closeness of their spectral absorption peaks. There are no other more accurate methods for estimating the two in a mixture than the proposed method. The proposed method is considered one of the most direct and economical methods that do not require reagents or additional materials for conducting reactions and studying the optimal conditions for those interactions. Thus, it is considered one of the green chemistry techniques that reduce the use of chemicals and reagents in the process of estimating these drugs in a mixture and in a shorter period of time. The proposed method can be used to estimate the different properties in a mixture of the two compounds whose absorption spectra are close.
About the Authors
M. A. Mohammed
College of Education for Pure Sciences (Ibn-Al-Haitham)
Iraq
Iraq
Department of Chemistry,
University of Baghdad, Baghdad
K. A. Sadiq
College of Education for Pure Sciences (Ibn-Al-Haitham)
Iraq
Iraq
Department of Chemistry,
University of Baghdad, Baghdad
E. N. Mezaal
College of Education for Pure Sciences (Ibn-Al-Haitham)
Iraq
Iraq
Department of Chemistry,
University of Baghdad, Baghdad
D. F. Hassan
College of Education for Pure Sciences (Ibn-Al-Haitham)
Iraq
Iraq
Department of Chemistry,
University of Baghdad, Baghdad
References
1. Dobrina Doncheva Tsvetkova, Stefka Achkova Ivanova, Indo Am. J. Pharm. Sci., 5, No. 8, 1–9 (2018), doi: 10.5281/zenodo.1411659.
2. Antonella S. Araujo-Fernandez, José C. Uribe-Villarreal, Enma Perez-Chauca, Pedro M. Alva-Plasencia, Olga E. Caballero-Aquiño, Mayar L. Ganoza-Yupanqui, J. Pharm. & Pharm. Res., 10, No. 2, 310–317 (2022), doi: 10.56499/jppres21.1212_10.2.310.
3. Asmaa Ghanim Dawood, Lazeeza Sattar Omer, Iraqi J. Sci., 61, No. 12, 3141–3153 (2020), doi: 10.24996/ijs.2020.61.12.1.
4. A. Latif, F. Akbar, A. J. Khan, H. Shafi, M. Mazhar, Pharm. Anal. Acta, 9, No. 7, 1–6 (2018), doi: 10.4172/2153-2435.1000592.
5. Ü. Özgür, D. Erdal, Sakarya University J. Science, 25, No. 6, 1432–1437 (2021), doi: 10.16984/saufenbilder.989654.
6. D. Nagavalli, V. Vaidhyalingam, A. Santha, A. Sankar, O. Divya, Acta Pharm., 60, No. 2, 141–152 (2010), doi: 10.2478/v10007-010-0017-8.
7. T. B. Tran, P. T. Le, V. H. Nguyen, D. G. Nguyen, D. L. Nguyen, T. Q. Nguyen, J. Anal. Methods in Chem., ID 2754133, 1–8 (2021), doi: 10.1155/2021/2754133.
8. Maneesha C. Abeysekera, Muditha B. Herath, Shehani H. Basnagoda, Udaya K. Jayasundara, Systematic Rev. Pharm., 13, No. 2, 116–121 (2022), doi: 10.31858/0975-8453.13.2.116-121.
9. Rudy Bonlio, Lívia Botacini Favoretto, Gislaine Ribeiro Pereira, Roberta de Cássia Pimentel Azevedo, Magali Benjamim de Araújo, Brazilian J. Pharm. Sci., 46, No. 1, 147–155 (2010), doi: 10.1590/S1984-82502010000100017.
10. Rubén M. Maggio, Patricia M. Castellano, Teodoro S. Kaufman, Anal. and Bioanal. Chem., 391, No. 8, 2949–2955 (2008), doi: 10.1007/s00216-008-2180-z.
11. Nief Rahman Ahmed, Mohammad Jassim Essa, Muna Sobhi Abdullah, World J. Pharm. Res., 8, No. 11, 89–96 (2019), doi: 10.20959/wjpr201911-15890.
12. Elham N. Mezaal, Maha A. Mohammed, Kawther Ahmed Sadi, J. Med. Chem. Sci., 6, No. 5, 1112–1119 (2023), doi: 10.26655/JMCHEMSCI.2023.5.16.
13. T. P. Aneesh, Renju Radhakrishnan, P. M. Aravind, Anuja Sasidharan, Manisha Choyal, Int. Res. J. Pharm., 6, No. 7, 453–457 (2015), doi: 10.7897/2230-8407.06793.
14. Q. Shuhong, L. Kai, M. Panqin, W. Menglin, C. Hongming, X. Xiaochao, H. Xiaoli, W. Yongjun, Current Pharm. Analysis, 11, No. 1, 25–34 (2015), doi: 10.2174/1573412910999141010152758.
15. Amna B. W. E. Mohammed, Elsadig H. Rudwan, Int. J. Pharm. Sci. Res., 7, No. 6, 2343–2351 (2016), doi: 10.13040/IJPSR.0975-8232.7(6).2343-51.
16. Lisa Foley, Jennifer Toney, James W. Barlow,Maura O’Connor, Deirdre Fitzgerald-Hughes, Zebunnissa Ramtoola, Molecules, 26, No. 2, 1–9 (2021), doi: 10.3390/molecules26020301.
17. Shereen Shalan, Jenny Jeehan Nasr, Royal Soc. Open Sci., 6, No. 4, 2–6 (2019), doi: 10.1098/rsos.190310.
18. S. A. Soad, E. Magda, M. Khaled, E. I. Adel, Royal Soc. Open Sci., 9, No. 6, 1–10 (2022), doi: 10.1098/rsos.220250.
19. Tadiboyina Sirisha, Bannimath Gurupadayya, Sridhar Siddiraju, Adv. Pharm. Bull., 5, No. 1, 133–136 (2015), doi: 10.5681/apb.2015.019.
20. Priyanka A. Shah, Primal Sharma, Jaivik V. Shah, Mallika Sanyal, Pranav S. Shrivastav, Turkish J. Chem., 39, 714–733 (2015), doi: 10.3906/kim-1502-4.
21. X. L. Jun, H. M. Zhen, Z. Wenlin, Determination of nitrosamine impurities in losartan potassium drug substance and drug product using the Xevo TQ-S micro and Atlantis premier BEH C18 AX column. Waters Corporation 720007393, 1–13 (2021).
22. L. Liangxing, L. Caiyun, X. Xueyi, G. Chongkai, L. Ning, J. Chromatogr. Sci., 54, No. 8, 1415–1420 (2016), doi: 10.1093/chromsci/bmw101.
23. Vijaya Kumari Karra, Nageswara Rao Pilli, Jaswanth Kumar Inamadugu, J. V. L. N. Seshagiri Rao, Pharm. Methods, 3, No. 1, 18–25 (2012), doi: 10.4103/2229-4708.97711.
24. C. Sandeep, S. Aman, M. Chandrasekar, P. Manoj, Drug Discovery and Development, 2, 1–3 (2020).
25. M. Chander, B. Saikat, V. Samir, Agilent Technol., 555, 1–4 (2020).
26. M. I. Walash, M. M. Sharaf El-Din, N. M. El-Enany, M. I. Eid, S. M. Shalan, Chem. Central J., 6, No. 13, 1–12 (2012), doi: 10.1186/1752-153x-6-13.
27. E. Souri, A. N. Aghdami, N. Adib, Res. Pharm. Sci., 9, No. 3, 199–206 (2014).
28. Ahmed H. Naggar, Ahmed Kotb, Ahmed A. Gahlan, Mahmoud H. Mahross, Abd El-Aziz Y. El-Sayed, Adel A. Abdelwahab, Chemosensors, 9, No. 2, 1–22 (2021), doi: 10.3390/chemosensors9020035.
29. M. Abdulbari, A. Zainab, J. Phys.: Conf. Ser., 1032, No. 1, 1–9 (2018), doi: 10.1088/1742-6596/1032/1/012064.
30. A. A. Othman, R. I. El-Bagary, E. F. Elkady, M. M. El-Kerdawy, Pharm. Anal. Acta, 7, No. 7, 1–8 (2016), doi: 10.4172/2153-2435.1000501.
31. Azza A. Attia, Alexandria J. Pharm. Sci., 8, No. 1, 15–18 (1994).
32. Farhan Ahmed Siddiqui, Nawab Sher, Najmul Hasan, Nighat Shafi, Hina Shamshad, Mansoor Ali Beg, Ali Akbar Sial, Alisha Wafa Sial, World Appl. Sci. J., 32, No. 7, 1418–1422 (2014), doi: 10.5829/idosi.wasj.2014.32.07.1120.
33. Safila Naveed, Nimra Waheed, Safeena Nazeer, Hina Rehman, Int. J. Appl. Sci.-Res. and Rev., 2, No. 1, 1–5 (2015).
34. M. Parag, G. P. Senthilkumar, Am. J. Pharm. Res., 10, No. 1, 137–147 (2020), doi: 10.46624/ajptr.2020.v10.i1.012.
35. Rania N. El-Shaheny, Fathalla F. Belal, J. Chem., 1, 1–9 (2015), doi: 10.1155/2015/293719.
36. Mohamed I. Walash, Mohie M. Kh. Sharaf El-din, Nahed M. El-enany, Manal I. Eid, Shereen M. Shalan, Chem. Central J., 6, No. 13, 1–12 (2012), doi: 10.1186/1752-153X-6-13.
37. K. Sujana, M. Z. Hamuthal, V. S. Murthy, N. Shravani, Pharm. Anal. Acta, 6, No. 1, 1–6 (2015), doi: 10.4172/2153-2435.1000324.
38. A. A. Tamer, G. M. Gehad, E. N. S. Adel, Egypt. J. Chem., 64, No. 7, 3323–3334 (2021), doi: 10.21608/EJCHEM.2021.50147.3300.
39. H. M. K. K. Inas, J. Pure & Appl. Sci., 31, No. 1, 75–87 (2018), doi: 10.30526/31.1.1855.
40. S. T. Nagam, A. Y. Omar, Baghdad Sci. J., 18, No. 3, 565–574 (2021), doi: 10.21123/bsj.2021.18.3.0565.
41. Nagham S. Turkey, Jalal N. Jeber, Baghdad Sci. J., 19, No. 1, 141–154 (2022), doi: 10.21123/bsj.2022.19.1.0141
42. Nagham S. Turkey, Jalal N. Jeber, Chem. and Chem. Technol., 16, No. 4, 600–613 (2022), doi: 10.23939/chcht16.04.600.
43. V. Montazeralmahdi, A. Sheibani, M. R. Shishehbore, J. Appl. Spectrosc., 86, 843–847 (2019), doi: 10.1007/s10812-019-00904-3.
44. S. M. Soliman, H. M. Y. El-Agizy, E. Abd El Aziz, J. Appl. Spectrosc., 81, 509–518 (2014), doi: 10.1007/s10812-014-9963-0.
45. S. R. Patra, A. Bali, M. Saha, J. Appl. Spectrosc., 88, 1088–1094 (2021), doi: 10.1007/s10812-021-01284-3.
46. P. Singh, A. Bali, J. Appl. Spectrosc., 89, 1085–1091 (2023), doi: 10.1007/s10812-023-01471-4.
47. I. A. Darwish, A. S. Khedr, H. F. Askal, R. M. Mahmoud, J. Appl. Spectrosc., 73, 792–797 (2006), doi: 10.1007/s10812-006-0157-2.
48. R. Chadha, A. Bali, J. Appl. Spectrosc., 83, No. 2, 288–293 (2016), doi: 10.1007/s10812-016-0283-4.
49. S. K. Dash, S. K. Achariya, P. S. Das, N. K. Kumar, Ch. N. Patra, J. Appl. Spectrosc., 88, No. 6, 1276–1283 (2022), doi: 10.1007/s10812-022-01309-5.
50. Tanvi Gupta, Alka Bali, Marella Mahesh, J. Appl. Spectrosc., 90, No. 4 (2023), doi: 10.1007/s10812-023-01612-9.
Review
For citations:
Mohammed M.A., Sadiq K.A., Mezaal E.N., Hassan D.F. Spectrophotometric Method Using the Derivative for the Determination of the Drug Losartan. Zhurnal Prikladnoii Spektroskopii. 2024;91(3):471. (In Russ.)
Views: 63
Email this article 